Moderna Therapeutics joins IQ Consortium
The IQ Consortium is excited to announce its newest member, Moderna Therapeutics.
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response.
Moderna Therapeutics will be represented on the IQ Board of Directors by Chris Bral and Nagendra Chemuturi.